1. Home
  2. CRNX vs BOOT Comparison

CRNX vs BOOT Comparison

Compare CRNX & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • BOOT
  • Stock Information
  • Founded
  • CRNX 2008
  • BOOT 1978
  • Country
  • CRNX United States
  • BOOT United States
  • Employees
  • CRNX N/A
  • BOOT N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • BOOT Clothing/Shoe/Accessory Stores
  • Sector
  • CRNX Health Care
  • BOOT Consumer Discretionary
  • Exchange
  • CRNX Nasdaq
  • BOOT Nasdaq
  • Market Cap
  • CRNX 2.8B
  • BOOT 3.3B
  • IPO Year
  • CRNX 2018
  • BOOT 2014
  • Fundamental
  • Price
  • CRNX $30.16
  • BOOT $164.30
  • Analyst Decision
  • CRNX Strong Buy
  • BOOT Strong Buy
  • Analyst Count
  • CRNX 10
  • BOOT 12
  • Target Price
  • CRNX $75.00
  • BOOT $176.17
  • AVG Volume (30 Days)
  • CRNX 676.7K
  • BOOT 638.9K
  • Earning Date
  • CRNX 08-07-2025
  • BOOT 08-06-2025
  • Dividend Yield
  • CRNX N/A
  • BOOT N/A
  • EPS Growth
  • CRNX N/A
  • BOOT 22.50
  • EPS
  • CRNX N/A
  • BOOT 5.88
  • Revenue
  • CRNX $760,000.00
  • BOOT $1,911,104,000.00
  • Revenue This Year
  • CRNX $402.12
  • BOOT $14.33
  • Revenue Next Year
  • CRNX $770.88
  • BOOT $12.95
  • P/E Ratio
  • CRNX N/A
  • BOOT $27.98
  • Revenue Growth
  • CRNX N/A
  • BOOT 14.64
  • 52 Week Low
  • CRNX $24.10
  • BOOT $86.17
  • 52 Week High
  • CRNX $62.53
  • BOOT $176.64
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 41.11
  • BOOT 62.11
  • Support Level
  • CRNX $32.05
  • BOOT $156.05
  • Resistance Level
  • CRNX $31.56
  • BOOT $165.05
  • Average True Range (ATR)
  • CRNX 1.08
  • BOOT 4.77
  • MACD
  • CRNX -0.18
  • BOOT -1.84
  • Stochastic Oscillator
  • CRNX 5.25
  • BOOT 62.19

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About BOOT Boot Barn Holdings Inc.

Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.

Share on Social Networks: